Neuroprotective agents for neonatal hypoxic–ischemic brain injury
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 20 (11) , 1372-1381
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
- Muscular Dystrophy Association
- ALS Therapy Alliance
This publication has 95 references indexed in Scilit:
- Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-IschemiaInternational Journal of Molecular Sciences, 2013
- Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia–ischemiaPediatric Research, 2012
- Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)BMC Pediatrics, 2012
- Neuronal Nitric Oxide Synthase Inhibition Prevents Cerebral Palsy following Hypoxia-Ischemia in Fetal Rabbits: Comparison between JI-8 and 7-NitroindazoleDevelopmental Neuroscience, 2011
- The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brainInternational Journal of Developmental Neuroscience, 2011
- The Antiapoptotic Activity of Melatonin in Neurodegenerative DiseasesCNS Neuroscience & Therapeutics, 2009
- Normal Development of Brain CircuitsNeuropsychopharmacology, 2009
- Methazolamide and Melatonin Inhibit Mitochondrial Cytochrome C Release and Are Neuroprotective in Experimental Models of Ischemic InjuryStroke, 2009
- Brain Injury Expands the Numbers of Neural Stem Cells and Progenitors in the SVZ by Enhancing Their Responsiveness to EGFASN Neuro, 2009
- Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008